The ROE as of December 2025 (TTM) for CARsgen Therapeutics Holdings Limited (2171.HK) is -39.53%

According to CARsgen Therapeutics Holdings Limited’s latest financial reports and current stock price. The company's current ROE is -39.53%. This represents a change of 145.45% compared to the average of -16.11% of the last 4 quarters.

CARsgen Therapeutics Holdings Limited (2171.HK) Historical ROE (quarterly & annually)

How has 2171.HK ROE performed in the past?

The mean historical ROE of CARsgen Therapeutics Holdings Limited over the last ten years is -35.29%. The current -39.53% ROE has changed 12.01% with respect to the historical average. Over the past ten years (40 quarters), 2171.HK's ROE was at its highest in in the June 2020 quarter at 72.62%. The ROE was at its lowest in in the December 2024 quarter at -37.77%.

CARsgen Therapeutics Holdings Limited (2171.HK) ROE by Quarter and Year

Discovering the peaks and valleys of CARsgen Therapeutics Holdings Limited ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

CARsgen Therapeutics Holdings Limited (2171.HK) Average ROE

How has 2171.HK ROE performed in the past?

The current ROE of CARsgen Therapeutics Holdings Limited (2171.HK) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

CARsgen Therapeutics Holdings Limited (2171.HK) ROE vs. Peers

How is 2171.HK’s ROE compared to its peers?

CARsgen Therapeutics Holdings Limited’s ROE is greater than CStone Pharmaceuticals (-71.29%), greater than Ascletis Pharma Inc. (-13.49%), less than Abbisko Cayman Limited (7.17%), greater than CK Life Sciences Int'l., (Holdings) Inc. (-7.77%), less than HBM Holdings Limited (18.28%), less than Nanjing Leads Biolabs Co Ltd (0%), less than Alphamab Oncology (12.63%), greater than Lepu Biopharma Co., Ltd. (-24.47%), greater than Ocumension Therapeutics (-6.71%), less than Brainaurora-b (49.83%),

Build a custom stock screener for CARsgen Therapeutics Holdings Limited (2171.HK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like CARsgen Therapeutics Holdings Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

CARsgen Therapeutics Holdings Limited (2171.HK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like CARsgen Therapeutics Holdings Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.